Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AMC303 |
Synonyms | |
Therapy Description |
AMC303 is an allosteric inhibitor of CD44v6, the co-receptor of c-MET, RON, and VEGFR2, which may result in decreased cell invasion and migration, and tumor regression (Cancer Res 2017;77(13 Suppl):Abstract nr 4911). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMC303 | AMC-303|AMC 303 | AMC303 is an allosteric inhibitor of CD44v6, the co-receptor of c-MET, RON, and VEGFR2, which may result in decreased cell invasion and migration, and tumor regression (Cancer Res 2017;77(13 Suppl):Abstract nr 4911). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|